Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Cell Reports|May 28, 2026
Chaperone-mediated autophagy is a tumor-suppressive mechanism in hepatocellular carcinomaKhushbu Patel, Begoña Zapateria, Alexander J Ledet, et al.
Cell|April 9, 2013
Non-cell-autonomous tumor suppression by p53Amaia Lujambio, Leila Akkari, Janelle Simon, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Integrated in vivo functional screens and multi-omics analyses identify α-2,3-sialylation as essential for melanoma maintenancePraveen Agrawal, Shuhui Chen, Ana de Pablos, et al.
Endocrine-Related Cancer|March 4, 2008
Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutationsBranca M Cavaco, Pedro F Batista, Carmo Martins, et al.
Neoplasia (New York, N.Y.)|November 1, 2007
Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathwayDavid Blanco, Silvestre Vicent, Mario F Fraga, et al.
Cell Reports|January 19, 2022
The portrait of liver cancer is shaped by mitochondrial geneticsMrittika Chattopadhyay, Edmund Charles Jenkins, Ana Victoria Lechuga-Vieco, et al.
Hepatology (Baltimore, Md.)|February 2, 2021
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic ImplicationsJunyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Cancers|November 19, 2020
Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular CarcinomaLeyre Silva, Josune Egea, Lorea Villanueva, et al.
Cancer Cell|August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF SignalingZoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Frontiers in Immunology|January 11, 2020
Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell TherapiesTeresa Lozano, Silvia Chocarro, Celia Martin, et al.
Pageof 13